Francesco Santarelli
Bonn, NW 53127, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: May 12, 2023
Characterizing microglial senescence: Tau as a key player.
Journal: Journal of neurochemistry
Published: November 03, 2022
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study.
Journal: Alzheimer's research & therapy
Published: May 31, 2022
Systemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing.
Systemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing.
Journal: Journal of neurochemistry
Published: March 11, 2021
Interrelations of Alzheimer´s disease candidate biomarkers neurogranin, fatty acid-binding protein 3 and ferritin to neurodegeneration and neuroinflammation.
Journal: Journal of neurochemistry
Published: May 26, 2020
Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: October 22, 2019
Quantitative proteomics of synaptosome S-nitrosylation in Alzheimer's disease.
Journal: Journal of neurochemistry
Published: April 25, 2019
Dysregulation of TLR5 and TAM Ligands in the Alzheimer's Brain as Contributors to Disease Progression.
Journal: Molecular neurobiology
Published: November 02, 2018
Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's disease.
Journal: Alzheimer's research & therapy
Published: November 23, 2017
Last Updated: 09/26/2026